ARIX — Arix Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00- £183.80m
- £82.85m
- £0.11m
- 29
- 34
- 90
- 48
Annual cashflow statement for Arix Bioscience, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 42.8 | -75.6 | 126 | -61.1 | -27.6 |
| Depreciation | |||||
| Non-Cash Items | -53.1 | 67.1 | -133 | 55.1 | 22.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.19 | -0.485 | 0.118 | -1.4 | -0.114 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -11.1 | -8.47 | -6.73 | -7.14 | -4.64 |
| Capital Expenditures | -0.002 | -0.006 | -0.007 | -0.101 | -0.008 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -115 | 34.1 | 66.3 | 42.1 | -12.8 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -115 | 34.1 | 66.3 | 42 | -12.8 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 82.2 | -0.986 | 0 | -11.6 | -0.063 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -43.9 | 23.6 | 57.4 | 22.1 | -11.4 |